<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00373698</url>
  </required_header>
  <id_info>
    <org_study_id>IAC 06-073</org_study_id>
    <nct_id>NCT00373698</nct_id>
  </id_info>
  <brief_title>Re-Engineering Systems for the Primary Care Treatment for PTSD</brief_title>
  <acronym>RESPECT-PTSD</acronym>
  <official_title>Reengineering Systems for the Primary Care Treatment of PTSD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is an evaluation of a systemic intervention to enhance the delivery of care
      according to practice guidelines for posttraumatic stress disorder (PTSD). The immediate
      objectives are to (1) implement three component model (3CM) in VA primary care clinics; and
      (2) evaluate the effects of 3CM on clinician behavior and patient outcomes. The long-term
      objectives are to generate information to support implementation research on the RESPECT
      model for treating PTSD in primary care and ultimately, the implementation of the model in
      VHA to provide care to veterans with PTSD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      3CM consists of (1) a prepared practice, (2) care management, and (3) enhanced mental health
      support. A prepared practice refers to education for primary care clinicians and office staff
      about practice guidelines and evidence-based care, the skills needed for use of assessment
      measures, and the use of communication forms and routines. The education plan consists of
      predisposing activities, including active teaching and learning, and enabling and reinforcing
      activities in order to help clinicians use newly acquired skills and to reinforce the
      continued use of these skills in practice. Care management is accomplished by telephone,
      usually by a centrally located care manager during acute phase treatment and follow up to
      answer patient questions, promote adherence to the clinician's management plan, and help
      patients overcome barriers to adherence. Enhanced mental health support is provided by a
      psychiatrist who supervises care managers by telephone, provides informal consultation to
      primary care clinicians, and helps to increase the quantity or quality of mental health
      referral resources.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PTSD Symptom Severity</measure>
    <time_frame>3 and 6 months after initial assessment</time_frame>
    <description>PTSD Symptom Severity was measured using the Postraumatic Diagnostic Scale (PDS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>3 and 6 months after initial assessment</time_frame>
    <description>Measure using the Hopkins Symptom Checklist-20</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 Mental Component</measure>
    <time_frame>3 and 6 months after initial assessment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 Physical Component</measure>
    <time_frame>3 and 6 months after initial assessment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">195</enrollment>
  <condition>Stress Disorders, Posttraumatic</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Three Component Model</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Three Component Model of Collaborative Care: Patients randomized to 3CM will receive telephone care management along with usual care by VA clinicians.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients randomized to &quot;Usual Care&quot; will receive care as usual by VA clinicians.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Three Component Model of Collaborative Care</intervention_name>
    <description>Patients randomized to 3CM will receive telephone care management along with usual care by VA clinicians.</description>
    <arm_group_label>Three Component Model</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Military Veterans in Primary Care Clinics who meet diagnostic criteria for PTSD in one
             of the 5 sites in Texas where this study is being conducted.

          -  Must have regular access to a telephone and speak English.

        Exclusion Criteria:

          -  Cognitive impairment

          -  A history of psychosis or mania

          -  Prominent current suicidal ideation

          -  Current substance dependence

          -  Current engagement in mental health treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paula P Schnurr, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>White River Junction VA Medical Center, White River Junction, VT</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Texas Veterans Health Care System, Temple, TX</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Texas Veterans Health Care System Waco VA Medical Center, Waco, TX</name>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <zip>76711</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>White River Junction VA Medical Center, White River Junction, VT</name>
      <address>
        <city>White River Junction</city>
        <state>Vermont</state>
        <zip>05009-0001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Schnurr PP, Friedman MJ, Oxman TE, Dietrich AJ, Smith MW, Shiner B, Forshay E, Gui J, Thurston V. RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial. J Gen Intern Med. 2013 Jan;28(1):32-40. doi: 10.1007/s11606-012-2166-6. Epub 2012 Aug 3.</citation>
    <PMID>22865017</PMID>
  </results_reference>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 6, 2006</study_first_submitted>
  <study_first_submitted_qc>September 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2006</study_first_posted>
  <results_first_submitted>July 31, 2014</results_first_submitted>
  <results_first_submitted_qc>November 3, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 7, 2014</results_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stress Disorders, Posttraumatic</keyword>
  <keyword>Delivery of Health Care, Integrated</keyword>
  <keyword>Primary Health Care</keyword>
  <keyword>Veterans</keyword>
  <keyword>Depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Three Component Model of Collaborative Care and Usual Care</title>
          <description>Participants randomized to this arm received the Three Component Model of Collaborative Care (3CM) as well as usual care. 3CM model consists of 1) education and tools for primary care clinicians and staff including content regarding PTSD; 2) telephone care management by a centrally located care manager (the purpose of the calls was to identify barriers to adherance with the primary care provider's plan, aid participant to overcome them, and measure treatment response. Calls occurred 1, 4, and 8 weeks after the initial visit and then every 4 weeks for 6 months or until a participant acheived 30% reduction in PTSD symptoms as measure by the PCL); 3) support from a psychiatrist who supervises care managers by telephone, provides consultation to primary care clinicians, and facilitates mental health referral. Participant's &quot;Usual Care&quot; is at the VA provider's discretion and could include referral to mental health specialty care.specialty care.</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>Participants randomized to &quot;Usual Care&quot; received care at the VA provider's discretion and could include referral to mental health specialty care.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="96"/>
                <participants group_id="P2" count="99"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="85"/>
                <participants group_id="P2" count="99"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>To be included, subjects had to meet diagnostic criteria for PTSD, have regular access to a telephone, and speak English. Exclusion criteria were cognitive impairment, history of psychosis or mania, prominent current suicidal ideation, current substance dependence, and current engagement in mental health treatment</population>
      <group_list>
        <group group_id="B1">
          <title>Three Component Model</title>
          <description>Three Component Model of Collaborative Care: Patients randomized to 3CM will receive telephone care management along with usual care by VA clinicians.</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>Patients randomized to &quot;Usual Care&quot; will receive care as usual by VA clinicians.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="96"/>
            <count group_id="B2" value="99"/>
            <count group_id="B3" value="195"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <title>Age, &gt;=18</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.1">43.1-49.1 (95% confidence interval)</measurement>
                    <measurement group_id="B2" value="44.4">41.3-47.5 (95% confidence interval)</measurement>
                    <measurement group_id="B3" value="NA">The data are locked and the total can not be calculated.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="89"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="96"/>
                    <measurement group_id="B2" value="99"/>
                    <measurement group_id="B3" value="195"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PTSD symptom severity (used Posttraumatic Diagnostic Scale (PDS))</title>
          <description>The PDS yields a total severity score (ranging from 0 to 51, where 0 is the best and 51 is the worst) that largely reflects the frequency of the 17 symptoms of PTSD. 17 symptoms of PTSD are rated individually on a scale from 0 to 3, with 3 being the highest. Total severity score is calculated by adding the number from each individual symptom. A PDS Profile Report also provides a preliminary determination of DSM-IV PTSD diagnostic status, a count of the number of symptoms endorsed, a rating of symptom severity, and a rating of the level of impairment of functioning.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.2" spread="8.3"/>
                    <measurement group_id="B2" value="34.0" spread="9.7"/>
                    <measurement group_id="B3" value="NA">The data are locked and can not be calculated</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Depression (Hopkins Symptom Checklist-20)</title>
          <description>Depression severity (ranging 0-4) was measured with the Hopkins Symptom Checklist-20. This self-assessment measure consists of 20 questions with possible scores ranging from 0 to 4, with higher scores indicating worse symptoms. Means and the standard deviations of the 20 questions are presented with higher scores indicating worse depression.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.98" spread="0.69"/>
                    <measurement group_id="B2" value="2.06" spread="0.78"/>
                    <measurement group_id="B3" value="NA">The data are locked and can not be calculated</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>SF-36 Mental Component</title>
          <description>SF-36 Mental Component is measured as part of SF-36 Health Survey. Scores can range from 0 (poorest possible health ) to 100 (highest possible health).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.8" spread="8.8"/>
                    <measurement group_id="B2" value="32.7" spread="8.1"/>
                    <measurement group_id="B3" value="NA">The data are locked and can not be calculated.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>SF-36 Physical Component</title>
          <description>SF-36 Physical Component is measured as part of SF-36 Health Survey. Scores can range from 0 (poorest possible health ) to 100 (highest possible health).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.2" spread="13.0"/>
                    <measurement group_id="B2" value="43.4" spread="12.6"/>
                    <measurement group_id="B3" value="NA">The data are locked and can not be calculated.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>PTSD Symptom Severity</title>
        <description>PTSD Symptom Severity was measured using the Postraumatic Diagnostic Scale (PDS)</description>
        <time_frame>3 and 6 months after initial assessment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm1/Three Component Model of Care Collaborative Care</title>
            <description>Three Component Model of Collaborative Care: Patients randomized to 3CM will receive telephone care management along with usual care by VA clinicians.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2/Usual Care</title>
            <description>Patients randomized to &quot;Usual Care&quot; will receive care as usual by VA clinicians.</description>
          </group>
        </group_list>
        <measure>
          <title>PTSD Symptom Severity</title>
          <description>PTSD Symptom Severity was measured using the Postraumatic Diagnostic Scale (PDS)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="96"/>
                <count group_id="O2" value="99"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>3 months after initial assessment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.4" spread="10.2"/>
                    <measurement group_id="O2" value="31.5" spread="10.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months after initial assessment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.2" spread="10.3"/>
                    <measurement group_id="O2" value="29.9" spread="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Depression</title>
        <description>Measure using the Hopkins Symptom Checklist-20</description>
        <time_frame>3 and 6 months after initial assessment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm1/Three Component Model of Care Collaborative Care</title>
            <description>Three Component Model of Collaborative Care: Patients randomized to 3CM will receive telephone care management along with usual care by VA clinicians.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2/Usual Care</title>
            <description>Patients randomized to &quot;Usual Care&quot; will receive care as usual by VA clinicians.</description>
          </group>
        </group_list>
        <measure>
          <title>Depression</title>
          <description>Measure using the Hopkins Symptom Checklist-20</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="96"/>
                <count group_id="O2" value="99"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>3 months after initial assessment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.8"/>
                    <measurement group_id="O2" value="1.84" spread="0.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months after initial assessment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.81" spread="0.84"/>
                    <measurement group_id="O2" value="1.83" spread="0.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SF-36 Mental Component</title>
        <time_frame>3 and 6 months after initial assessment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm1/Three Component Model of Care Collaborative Care</title>
            <description>Three Component Model of Collaborative Care: Patients randomized to 3CM will receive telephone care management along with usual care by VA clinicians.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2/Usual Care</title>
            <description>Patients randomized to &quot;Usual Care&quot; will receive care as usual by VA clinicians.</description>
          </group>
        </group_list>
        <measure>
          <title>SF-36 Mental Component</title>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="96"/>
                <count group_id="O2" value="99"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Mental Component-3 months after initial assessment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.9" spread="8.3"/>
                    <measurement group_id="O2" value="33.8" spread="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental Component-6 months after initial assessment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.7" spread="9.4"/>
                    <measurement group_id="O2" value="33.4" spread="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SF-36 Physical Component</title>
        <time_frame>3 and 6 months after initial assessment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Three Component Model</title>
            <description>Three Component Model of Collaborative Care: Patients randomized to 3CM will receive telephone care management along with usual care by VA clinicians.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Patients randomized to &quot;Usual Care&quot; will receive care as usual by VA clinicians.</description>
          </group>
        </group_list>
        <measure>
          <title>SF-36 Physical Component</title>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="96"/>
                <count group_id="O2" value="99"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Physical Component-3 months after initial assessme</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.8" spread="13.1"/>
                    <measurement group_id="O2" value="43.7" spread="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physical Component-6 monthsafter initial assessmen</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.4" spread="12.6"/>
                    <measurement group_id="O2" value="44.8" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Three Component Model</title>
          <description>Three Component Model of Collaborative Care: Patients randomized to 3CM will receive telephone care management along with usual care by VA clinicians.</description>
        </group>
        <group group_id="E2">
          <title>Usual Care</title>
          <description>Patients randomized to &quot;Usual Care&quot; will receive care as usual by VA clinicians.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="96"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="99"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="96"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="99"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="99"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Paula Schnurr and Dr. Mathew Friedman</name_or_title>
      <organization>VA Medical Center, White River Junction, VT</organization>
      <phone>802-296-5132</phone>
      <email>Paula.Schnurr@va.gov; Matthew.Friedman@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

